Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Linxiao Sun

Matched on ORCID iD 0000-0001-5849-4881; OpenAlex author ID A5101421188. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2019: 1 paper · 2020: 3 papers · 2021: 5 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 11

  1. Bergamottin demonstrates preclinical effectiveness against pancreatic cancer by modulating PPAR-γ to induce apoptosis. First author DOI 10.21037/tcr-2026-0837↗
  2. Agrimoniin sensitizes pancreatic cancer to apoptosis through ROS-mediated energy metabolism dysfunction. Last author DOI 10.1016/j.phymed.2021.153807↗
  3. Periplocin inhibits the growth of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling. First author DOI 10.1002/cam4.3611↗
  4. MK8722, an AMPK activator, inhibiting carcinoma proliferation, invasion and migration in human pancreatic cancer cells. Co-author DOI 10.1016/j.biopha.2021.112325↗
  5. Correction to: Chemopreventive effect of Betulinic acid via mTOR -Caspases/Bcl2/Bax apoptotic signaling in pancreatic cancer. Last author DOI 10.1186/s12906-021-03254-w↗
  6. Transcriptome and proteome analysis of the antitumor activity of maslinic acid against pancreatic cancer cells. Last author DOI 10.18632/aging.203623↗
  7. Fisetin inhibits the proliferation, migration and invasion of pancreatic cancer by targeting PI3K/AKT/mTOR signaling. Last author DOI 10.18632/aging.203713↗
  8. Chemopreventive effect of Betulinic acid via mTOR -Caspases/Bcl2/Bax apoptotic signaling in pancreatic cancer. Last author DOI 10.1186/s12906-020-02976-7↗
  9. KRT17 Functions as a Tumor Promoter and Regulates Proliferation, Migration and Invasion in Pancreatic Cancer via mTOR/S6k1 Pathway. Co-author DOI 10.2147/cmar.s243129↗
  10. CC-223, NSC781406, and BGT226 Exerts a Cytotoxic Effect Against Pancreatic Cancer Cells via mTOR Signaling. Last author DOI 10.3389/fphar.2020.580407↗
  11. Baohuoside I Inhibits the Proliferation of Pancreatic Cancer Cells via mTOR/S6K1-Caspases/Bcl2/Bax Apoptotic Signaling. Last author DOI 10.2147/cmar.s228926↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cheng Wang · 7 shared papers, 2019–2021 · strength 0.99
  2. Hewei Zhang · 4 shared papers, 2019–2022 · strength 0.56
  3. Hengyue Zhu · 3 shared papers, 2020–2021 · strength 0.45
  4. Yangyang Guo · 3 shared papers, 2020–2021 · strength 0.45
  5. Cheng Wang · 1 shared paper, 2026 · strength 0.43
  6. Qiangqiang Li · 1 shared paper, 2026 · strength 0.43
  7. Bicheng Chen · 3 shared papers, 2019–2021 · strength 0.41
  8. Chenlei Zheng · 2 shared papers, 2019–2020 · strength 0.21
  9. Gangyin Xie · 1 shared paper, 2021 · strength 0.19
  10. Xiandong Zhu · 1 shared paper, 2022 · strength 0.15
  11. Bicheng Chen · 1 shared paper, 2022 · strength 0.15
  12. Wujun Geng · 1 shared paper, 2021 · strength 0.15
  13. Yanyi Xiao · 1 shared paper, 2021 · strength 0.14
  14. Ding Li · 1 shared paper, 2020 · strength 0.11
  15. Fubiao Ni · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.